1.Yeh LC, Huang PW, Hsieh KH, Wang CH, Kao YK, Lin TH, Lee XL: Elevated Plasma Levels of Gas6 Are Associated with Acute Lung Injury in Patients with Severe Sepsis. Tohoku J Exp Med 2017, 243(3):187–193.
2.Kida Y, Ohshimo S, Shime N: Optimal Cutoff Value for Lung Injury Prediction Score and Potential Confounders for Identifying the Risk of Developing Acute Respiratory Distress Syndrome. Crit Care Med 2017, 45(6):e624-e625.
3.Butt Y, Kurdowska A, Allen TC: Acute Lung Injury: A Clinical and Molecular Review. Arch Pathol Lab Med 2016, 140(4):345–350.
4.Tang L, Bai J, Chung CS, Lomas-Neira J, Chen Y, Huang X, Ayala A: Active players in resolution of shock/sepsis induced indirect lung injury: immunomodulatory effects of Tregs and PD–1. J Leukoc Biol 2014, 96(5):809–820.
5.Kang MJ, Yoon CM, Nam M, Kim DH, Choi JM, Lee CG, Elias JA: Role of Chitinase 3-Like–1 in Interleukin–18-Induced Pulmonary Type 1, Type 2, and Type 17 Inflammation; Alveolar Destruction; and Airway Fibrosis in the Murine Lung. Am J Respir Cell Mol Biol 2015, 53(6):863–871.
6.Raphael I, Nalawade S, Eagar TN, Forsthuber TG: T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 2015, 74(1):5–17.
7.Jia L, Wu C: The biology and functions of Th22 cells. Adv Exp Med Biol 2014, 841:209–230.
8.Hernandez P, Gronke K, Diefenbach A: A catch–22: Interleukin–22 and cancer. Eur J Immunol 2018, 48(1):15–31.
9.Li J, Li M, Su L, Wang H, Xiao K, Deng J, Jia Y, Han G, Xie L: Alterations of T helper lymphocyte subpopulations in sepsis, severe sepsis, and septic shock: a prospective observational study. Inflammation 2015, 38(3):995–1002.
10.Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME et al: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 2017, 43(3):304–377.
11.Gajic O, Dabbagh O, Park PK, Adesanya A, Chang SY, Hou P, Anderson H, 3rd, Hoth JJ, Mikkelsen ME, Gentile NT et al: Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 2011, 183(4):462–470.
12.Kalbitz M, Karbach M, Braumueller S, Kellermann P, Gebhard F, Huber-Lang M, Perl M: Role of Complement C5 in Experimental Blunt Chest Trauma-Induced Septic Acute Lung Injury (ALI). PLoS One 2016, 11(7):e0159417.
13.Szabo K, Papp G, Szanto A, Tarr T, Zeher M: A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjogren’s syndrome and systemic lupus erythematosus. Clin Exp Immunol 2016, 183(1):76–89.
14.Lu T, Liu Y, Yu S, Yin C, Li P, Ye J, Ma D, Ji C: Increased frequency of circulating Th22 cells in patients with B-cell non-Hodgkin’s lymphoma. Oncotarget 2016, 7(35):56574–56583.
15.Azizi G, Simhag A, El Rouby NM, Mirshafiey A: Th22 Cells Contribution in Immunopathogenesis of Rheumatic Diseases. Iran J Allergy Asthma Immunol 2015, 14(3):246–254.
16.Liu T, Peng L, Yu P, Zhao Y, Shi Y, Mao X, Chen W, Cheng P, Wang T, Chen N et al: Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer. J Clin Immunol 2012, 32(6):1332–1339.
17.de Lima Silveira E, de Sousa JR, de Sousa Aarao TL, Fuzii HT, Dias Junior LB, Carneiro FR, Quaresma JA: New immunologic pathways in the pathogenesis of leprosy: role for Th22 cytokines in the polar forms of the disease. J Am Acad Dermatol 2015, 72(4):729–730.
18.Liu X, Yang J, Deng W: The inflammatory cytokine IL–22 promotes murine gliomas via proliferation. Exp Ther Med 2017, 13(3):1087–1092.
19.Gupta DL, Bhoi S, Mohan T, Galwnkar S, Rao DN: Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with post traumatic sepsis. Cytokine 2016, 88:214–221.
20.Kumar V: T cells and their immunometabolism: A novel way to understanding sepsis immunopathogenesis and future therapeutics. Eur J Cell Biol 2018, 97(6):379–392.
21.McAleer JP, Kolls JK: Directing traffic: IL–17 and IL–22 coordinate pulmonary immune defense. Immunol Rev 2014, 260(1):129–144.
22.Jie Z, Liang Y, Yi P, Tang H, Soong L, Cong Y, Zhang K, Sun J: Retinoic Acid Regulates Immune Responses by Promoting IL–22 and Modulating S100 Proteins in Viral Hepatitis. J Immunol 2017, 198(9):3448–3460.
23.Zhang Y, Cobleigh MA, Lian JQ, Huang CX, Booth CJ, Bai XF, Robek MD: A proinflammatory role for interleukin–22 in the immune response to hepatitis B virus. Gastroenterology 2011, 141(5):1897–1906.
24.Liang SC, Nickerson-Nutter C, Pittman DD, Carrier Y, Goodwin DG, Shields KM, Lambert AJ, Schelling SH, Medley QG, Ma HL et al: IL–22 induces an acute-phase response. J Immunol 2010, 185(9):5531–5538.
25.Young RS, Wiles BM, McGee DW: IL–22 Enhances TNF-alpha- and IL–1-Induced CXCL8 Responses by Intestinal Epithelial Cell Lines. Inflammation 2017, 40(5):1726–1734.
26.Mizoguchi A, Yano A, Himuro H, Ezaki Y, Sadanaga T, Mizoguchi E: Clinical importance of IL–22 cascade in IBD. J Gastroenterol 2018, 53(4):465–474.
27.Jiang S, Shan F, Zhang Y, Jiang L, Cheng Z: Increased serum IL–17 and decreased serum IL–10 and IL–35 levels correlate with the progression of COPD. Int J Chron Obstruct Pulmon Dis 2018, 13:2483–2494.
28.Guan X, Lu Y, Wang G, Gibson P, Chen F, Fang K, Wang Z, Pang Z, Guo Y, Lu J et al: The Role of Regulatory T Cell in Nontypeable Haemophilus influenzae-Induced Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Mediators Inflamm 2018, 2018:8387150.